Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Didier Decaudin, et al. - The recent literature shows that interest in ocular adnexal lymphomas and their biologic and clinical characteristics—along with their possible association with Chlamydia psittaci infection and therapeutic management with rituximab or anti-Chlamydia psittaci antibiotic therapy—is considerable. These new data have modified the previously reported features of this disease and have made an updated review of the literature necessary

Related Articles

Treatment options for ocular adnexal lymphoma (OAL)
Clinical Ophthalmology, 11/25/09    Relevance Score: 81%%

Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes
Eye, 12/04/09    Relevance Score: 79%%

Ocular Surface Distribution and Pharmacokinetics of a Novel Ophthalmic 1% Azithromycin Formulation
Journal of Ocular Pharmacology and Therapeutics, 11/09/09    Relevance Score: 66%%

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy
International Journal of Hematology, 12/01/09    Relevance Score: 47%%

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Human Pathology, 12/14/09    Relevance Score: 46%%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address